The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Expertise in exosomes isolation and characterization will drive innovation in this field
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Support from DFC will help produce one billion vaccine doses by the end of 2022
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
